Wnt signaling in osteoblasts and bone diseases
JJ Westendorf, RA Kahler, TM Schroeder - Gene, 2004 - Elsevier
Recent revelations that the canonical Wnt signaling pathway promotes postnatal bone
accrual are major advances in our understanding of skeletal biology and bring tremendous …
accrual are major advances in our understanding of skeletal biology and bring tremendous …
Interaction of nuclear receptors with the Wnt/β-catenin/Tcf signaling axis: Wnt you like to know?
DJ Mulholland, S Dedhar, GA Coetzee… - Endocrine …, 2005 - academic.oup.com
The cross-regulation of Wnt/β-catenin/Tcf ligands, kinases, and transcription factors with
members of the nuclear receptor (NR) family has emerged as a clinically and …
members of the nuclear receptor (NR) family has emerged as a clinically and …
[HTML][HTML] Wnt/β-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor α
VJ Armstrong, M Muzylak, A Sunters, G Zaman… - Journal of Biological …, 2007 - ASBMB
The Wnt/β-catenin pathway has been implicated in bone cell response to their mechanical
environment. This response is the origin of the mechanism by which bone cells adjust bone …
environment. This response is the origin of the mechanism by which bone cells adjust bone …
[HTML][HTML] Wnt pathway activity in breast cancer sub-types and stem-like cells
Introduction Wnt signalling has been implicated in stem cell regulation however its role in
breast cancer stem cell regulation remains unclear. Methods We used a panel of normal and …
breast cancer stem cell regulation remains unclear. Methods We used a panel of normal and …
Canonical Wnt signaling is critical to estrogen-mediated uterine growth
Major biological effects of estrogen in the uterus are thought to be primarily mediated by
nuclear estrogen receptors, ERα and ERβ. We show here that estrogen in an ER …
nuclear estrogen receptors, ERα and ERβ. We show here that estrogen in an ER …
The regulation and role of osteopontin in malignant transformation and cancer
MK El-Tanani, FC Campbell, V Kurisetty, D Jin… - Cytokine & growth factor …, 2006 - Elsevier
Osteopontin (OPN) is a predominantly secreted extracellular matrix glycophosphoprotein
which binds to alpha v-containing integrins and has an important role in malignant cell …
which binds to alpha v-containing integrins and has an important role in malignant cell …
Genome-wide dynamics of chromatin binding of estrogen receptors α and β: mutual restriction and competitive site selection
Estrogen receptors ERα and ERβ, members of the nuclear receptor superfamily, exert
profound effects on the gene expression and biological response programs of their target …
profound effects on the gene expression and biological response programs of their target …
[HTML][HTML] Liganded androgen receptor interaction with β-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells
JE Pawlowski, JR Ertel, MP Allen, M Xu, C Butler… - Journal of Biological …, 2002 - ASBMB
A yeast two-hybrid assay was employed to identify androgen receptor (AR) protein partners
in gonadotropin-releasing hormone neuronal cells. By using an AR deletion construct (AR …
in gonadotropin-releasing hormone neuronal cells. By using an AR deletion construct (AR …
[HTML][HTML] Mesodermal fate decisions of a stem cell: the Wnt switch
LA Davis, NI Zur Nieden - Cellular and Molecular Life Sciences, 2008 - Springer
Stem cells are a powerful resource for cell-based transplantation therapies in
osteodegenerative disorders, but before some kinds of stem cells can be applied clinically …
osteodegenerative disorders, but before some kinds of stem cells can be applied clinically …
Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer
MPHM Jansen, T Knijnenburg, EA Reijm, I Simon… - Cancer research, 2013 - AACR
Aromatase inhibitors are the major first-line treatment of estrogen receptor–positive breast
cancer, but resistance to treatment is common. To date, no biomarkers have been validated …
cancer, but resistance to treatment is common. To date, no biomarkers have been validated …